← Back to Clinical Trials
Recruiting NCT04812730

NCT04812730 Multimodal Bio-mechanical Analysis of Adult Spinal Deformity With Sagittal Plane Misalignment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04812730
Status Recruiting
Phase
Sponsor Universitaire Ziekenhuizen KU Leuven
Condition Spinal Deformity
Study Type INTERVENTIONAL
Enrollment 265 participants
Start Date 2016-01
Primary Completion 2028-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 79 Years
Study Type INTERVENTIONAL
Interventions
2D versus 3D analysis of EOS stereo radiographic analysisStatic versus dynamic analysisPre- versus postoperative analysis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 265 participants in total. It began in 2016-01 with a primary completion date of 2028-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A good understanding of the principles of balance is vital to achieve optimal outcomes when treating spinal disorders. A complex interaction of the neuromotor system and muscular recruitment is necessary for ergonomic balance and deliberate displacement of the human body. Sagittal plane misalignment in spinal deformities challenges balance mechanisms used for maintenance of an upright posture. The occurrence of postoperative complications after spinal deformity correction like under-correction of sagittal misalignment, postoperative reciprocal changes in thoracic kyphosis, proximal junctional kyphosis and failure of instrumentation are possibly due to the current state-of-the art inadequate diagnostic work-up. Investigators do not fully understand the roll of vision and exact strategy of recruitment of neuromuscular units (trunk, pelvis, lower limbs) in patients with sagittal plane misalignment during standing and walking. To understand this, a dynamic evaluation of individuals with spinal deformities is needed. Currently there is only very little research performed in the field of clinical balance tests and instrumented movement analysis in patients with spinal deformity. The challenge for future studies is to further unravel the relation between trunk and lower limb movements, grouped into functional movement patterns. Moreover, additional information on trunk and lower limb kinetics and muscle activity (using dynamic electromyography (EMG)) will highly contribute to the understanding of this functional relationship, and will provide more in-depth insights into compensatory mechanisms of the trunk versus the lower limbs and vice versa.

Eligibility Criteria

Inclusion Criteria: * Pathological group 1. Age \>= 45 years 2. Diagnosis of adult congenital, degenerative, idiopathic or iatrogenic spinal deformity 3. Scoring at least 25 out of 30 on Mini Mental State Examination 4. Ability to walk at least 50 meters distance independently without a walking aid 5. Sagittal malalignment: PI-LL ≥ 25 degrees; sagittal vertical axis \>5cm; pelvic tilt \>25° and/or thoracic kyphosis \> 60° and/or coronal malalignment: thoracic scoliosis 30 ≥ degrees; thoracolumbar/lumbar scoliosis ≥ 30 degrees; global coronal malalignment \>3cm, posterior spinal fusion \> 4 levels + iliac fixation. 6. Ability and willingness of patient to attend follow-up visits and complete patient questionnaires 7. Completed patient informed consent * Control group 1. Asymptomatic adults not suffering from a spinal deformity leading to a pathological sagittal alignment presenting as volunteer in the University Hospitals Leuven, Belgium 2. Age \>=45 years old 3. Scoring at least 27 out of 30 on Mini Mental State Examination 4. Ability to walk at least 1000 meters distance independently without a walking aid 5. Ability and willingness of patient to attend follow-up visits and complete patient questionnaires 6. Completed patient informed consent Exclusion Criteria: * Pathological group 1. Age \< 45 years old 2. Absence of adult spinal deformity 3. Scoring less than 25 out of 30 on Mini Mental State Examination 4. Non-ability to walk at least 50 meters distance independently, with or without a walking aid. 5. Missing patient informed consent 6. Patients presenting with a neurological disease affecting balance other than Parkinson's disease such as stroke and/or Vestibular lesion 7. Patients with a current history of diagnosed musculoskeletal disorders of the trunk and/or lower extremities affecting the motor performance such as severe hip arthrosis with or without flexion contracture, severe knee arthrosis, severe ankle arthrosis, severe leg length discrepancy (\> 3 cm) 8. BMI\>30 * Control group 1. Age \< 45 years old 2. Backpain and/or Sciatica at time of the study 3. Presence of adult spinal deformity leading to a pathological sagittal alignment 4. Scoring less than 27 out of 30 on Mini Mental State Examination 5. Non-ability to walk at least 1000 meters distance independently without a walking aid 6. Missing patient informed consent 7. Patients presenting with a neurological disease affecting balance such as Stroke, Parkinson's disease and/or Vestibular lesion 8. Patients with a current history of diagnosed musculoskeletal disorders of the trunk and/or lower extremities affecting the motor performance such as severe hip arthrosis with or without flexion contracture, severe knee arthrosis, severe ankle arthrosis, severe leg length discrepancy (\> 3 cm) 9. BMI \> 27

Contact & Investigator

Central Contact

Lieven Moke

✉ lieven.moke@uzleuven.be

📞 +32 16 34 08 84

Principal Investigator

Lieven Moke

PRINCIPAL INVESTIGATOR

Universitaire Ziekenhuizen KU Leuven

Frequently Asked Questions

Who can join the NCT04812730 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 79 Years, studying Spinal Deformity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04812730 currently recruiting?

Yes, NCT04812730 is actively recruiting participants. Contact the research team at lieven.moke@uzleuven.be for enrollment information.

Where is the NCT04812730 trial being conducted?

This trial is being conducted at Leuven, Belgium.

Who is sponsoring the NCT04812730 clinical trial?

NCT04812730 is sponsored by Universitaire Ziekenhuizen KU Leuven. The principal investigator is Lieven Moke at Universitaire Ziekenhuizen KU Leuven. The trial plans to enroll 265 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology